Skip to content

CCS Case: Sickle Cell Vaso-Occlusive Crisis

Case: Sickle Cell Vaso-Occlusive Crisis

Clinical Setup

  • Presentation: 22-year-old male with homozygous sickle cell disease, severe bilateral leg and back pain (10/10) for 6 hours, low-grade fever, mild tachycardia, SpO2 95%, no chest pain or cough.
  • Location: Emergency Department.

Optimal Order Pathway

  1. Immediate Orders (Minute 0–1):
    • Pulse oximetry, continuous monitoring, BP q15min.
    • IV access, Normal saline or D5-0.45% IV @ maintenance–1.5x (avoid overhydration).
    • Supplemental O2 to keep SpO2 > 95%.
  2. Focused Exam (Minute 1–2):
    • Pain sites, lung exam (crackles, tachypnea — screen for acute chest), spleen, neuro screen (stroke signs), priapism check.
  3. Diagnostics (Minute 2–5):
    • CBC with reticulocyte count (compare to baseline Hb), CMP, type and screen.
    • CXR (new infiltrate = acute chest until proven otherwise), blood cultures if febrile, urinalysis.
  4. Therapeutics (Minute 5–15):
    • Aggressive pain control per patient-specific protocol: IV opioids (morphine or hydromorphone) with scheduled reassessment; add NSAIDs + acetaminophen; consider PCA.
    • Empiric antibiotics if febrile: Ceftriaxone + Azithromycin (encapsulated organisms + atypical for acute chest coverage).
    • Incentive spirometry q2h while awake (prevents acute chest); IVF continued modestly.
    • If acute chest syndrome (fever + chest symptoms + new infiltrate): O2, antibiotics, bronchodilators, simple or exchange transfusion per hematology.
    • Hematology consult; advance clock and reassess pain scores frequently.
  5. Disposition (Minute 15–20):
    • Admit if uncontrolled pain, fever, hypoxia, or acute chest features; ICU if acute chest with respiratory failure.
    • Continue home hydroxyurea; update vaccinations (pneumococcal, meningococcal, Hib, influenza).
  6. Final 2 Minutes:
    • Counsel on trigger avoidance (dehydration, cold, infection, alcohol), pain action plan, hydroxyurea adherence.
    • Schedule hematology and primary care follow-up; confirm penicillin prophylaxis status if indicated.